Key statistics
As of last trade Insulet Corp (GOV:FRA) traded at 247.60, -5.21% below its 52-week high of 261.20, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 247.60 |
---|---|
High | 247.60 |
Low | 247.60 |
Bid | 247.60 |
Offer | 253.30 |
Previous close | 250.40 |
Average volume | 27.00 |
---|---|
Shares outstanding | 70.14m |
Free float | 69.76m |
P/E (TTM) | 45.55 |
Market cap | 18.38bn USD |
EPS (TTM) | 5.75 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:05 GMT.
More ▼
- Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
- Insulet to Present at Upcoming Investor Conferences
- Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹)
- Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
- Omnipod® 5 App for iPhone® Now Fully Available in the United States
- Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
- Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
More ▼